High 3rd Qtr Net Income For Akzo

4 November 1997

Dutch chemicals group Akzo Nobel has posted net income of 455 millionguilders ($230.3 million) for the third quarter ended September, 1997, up 38.7% on the same period a year ago. Overall group sales reached 6.1 billion guilders, an increase of 11%, which was caused by volume gains and currency movements.

Pharmaceuticals, which contributed around 19.5% of total revenues, produced sales of 1.18 guilders, an increase of 23%, with operating income rising almost 30%. The boost in operating income was due to the strong performance of the group's subsidiary, Organon, which posted volume gains for oral contraceptives and the antidepressant Remeron (mirtazapine). All its other sectors, most notably chemicals, performed strongly.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight